Tuesday, June 20, 2017 10:19:47 AM
22nd Century Partners with The University of Virginia to Utilize Industrial Hemp to Clean Up and Reclaim Polluted Lands
Today 9:55 AM ET (Business Wire)Print
22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company focused on tobacco harm reduction and cannabis research, announced today that, together with The University of Virginia (UVA), it has launched a project aimed at utilizing novel varieties of industrial hemp to clean up and reclaim abandoned mine lands and other polluted areas. These polluted lands will be returned to productive use and cultivation through a cost-effective, plant-based process known as "phytoremediation."
22nd Century has developed proprietary hemp plants that are particularly well-suited for use in phytoremediation. These plants feature rapid growth rates and are highly efficient at absorbing toxins, metals and other soil contaminants. Similar varieties of hemp proved extremely effective in helping to remediate the land after the nuclear accidents at Chernobyl, Ukraine and Fukushima, Japan. In addition to removing contamination, hemp's deep tap roots alter soil structure, aerate the soil, and add organic matter deep into the soil profile.
In the Commonwealth of Virginia and elsewhere throughout the Appalachians, coal mining and other environmentally damaging activities have left behind vast stretches of compacted, polluted and generally untillable soil. This summer, researchers at UVA and its affiliate, UVA at Wise, will begin testing industrial hemp varieties developed by the 22nd Century-UVA partnership to improve soils in Virginia. Because there are more than 30,000 sites that require soil remediation in the United States alone, phytoremediation is expected to become a significant area of business for 22nd Century. UVA and 22nd Century will also investigate other uses of their phytoremediation hemp plants in Virginia, including the production of fiber, oils and other high value products, thus creating lucrative secondary markets for 22nd Century.
Based at the UVA-Wise campus, this landmark project reaches beyond conventional hemp remediation applications because UVA and 22nd Century are employing their combined biotechnology expertise to produce improved proprietary hemp varieties that are specifically designed for soil remediation. Such novel and powerful proprietary plants promise to become a central tool in farmland decontamination initiatives around the world.
"Our phytoremediation-optimized varieties of industrial hemp will open up new and lucrative markets for 22nd Century," explained Dr. Paul Rushton, 22nd Century's Vice President for Plant Biotechnology. "We are enthusiastic about the prospect of applying our biotechnology expertise to a challenging environmental problem. We see phytoremediation as an opportunity for 22nd Century to do very well... by doing good for the Earth."
"We are very excited about using 22nd Century's industrial hemp plants for land reclamation in Southwest Virginia, where years of poor land management practices and industrial mining have devastated soil quality and fertility," explained Dr. Michael Timko, the principal scientific investigator at UVA. "This is also a tremendous opportunity to partner with UVA-Wise where Dr. Ryan Huish and his colleagues have been studying the problems of mining land reclamation. Industrial hemp farming provides a new approach to not only rejuvenating the land but also the local economy in key portions of the Commonwealth of Virginia."
About 22nd Century Group, Inc.
Recent XXII News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:30:52 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:10:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 09:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 01:30:13 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/24/2024 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:30:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2024 01:04:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 10:02:41 PM
- 22nd Century Secures $3.2 Million to Date in Warrant Exchange Transaction • GlobeNewswire Inc. • 12/04/2023 12:07:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/01/2023 10:18:00 PM
- Pharma Stock Up Big After Second Major Announcement This Week • AllPennyStocks.com • 11/29/2023 03:55:00 PM
- Pharma Stock Up Big After Second Major Announcement This Week • AllPennyStocks.com • 11/29/2023 03:55:00 PM
- 22nd Century Appoints Larry Firestone as Chairman and CEO • GlobeNewswire Inc. • 11/29/2023 12:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 09:56:49 PM
- 22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise • GlobeNewswire Inc. • 11/27/2023 09:44:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 11:01:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:19:32 PM
- 22nd Century Group Continues VLN® Expansion, Now Retailing in More Than 5,100 Stores • GlobeNewswire Inc. • 11/08/2023 06:15:00 PM
- 22nd Century Group (XXII) Expands Reduced Nicotine Content Tobacco IP with Latest Technology License • GlobeNewswire Inc. • 11/07/2023 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 12:30:19 PM
- 22nd Century Group (XXII) Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/06/2023 12:30:00 PM
- 22nd Century Group (XXII) Supports FDA Policy Advancements, Proposed Menthol Ban Now at OMB • GlobeNewswire Inc. • 10/26/2023 12:30:00 PM
- 22nd Century Group (XXII) Reduces Debt by $8.1 Million • GlobeNewswire Inc. • 10/25/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 08:34:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM